Tickerplace logo

Tickerplace

Denali Therapeutics Inc. logo

DNLIDenali Therapeutics Inc.

DNLI Stock Price, Valuation & Chart | Denali Therapeutics Inc.

Compare
$17.610-0.73 (-3.98%)

At close · 16 Oct 2026, 08:00 pm

Sector: HealthcareIndustry: Biotechnology
OverviewFinancialsDividendsRatios

DNLI Historical price chart

DNLI Key Stats

Market Capitalization2.81B
PE Ratio-6.11
EPS-2.88
Trading Volume2.30M
Today's High/Low18.18/17.37
Dividend Yield0.00
52 Week High/Low27.3/13.75
Shares Outstanding159.85M
DNLI Financial Statement
DNLI Analyst ratings
DNLI Analysis & performance metrics

DNLI Company profile

Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers…

DNLI Management team

Management
Tyler M. Nielsen
Senior Vice President of Corporate Finance
Alexander O. Schuth M.D.CFO
Co-Founder, Chief Financial Officer, Chief Operating Officer & Secretary
Marc Tessier-Lavigne Ph.D.CTO
Co-Founder & Independent Director
Mark Rowen
Vice President of Corporate Development
Ryan J. Watts Ph.D.CEO
Co-Founder, President, Chief Executive Officer & Director
Joe Lewcock Ph.D.
Chief Scientific Officer
Laura Hansen Ph.D.
Vice President of Investor Relations
Dana Andersen
Chief Technical and Manufacturing Officer
Total 8 executives

DNLI Frequently asked questions

What is Denali Therapeutics Inc. (DNLI) Stock Price?

Current stock price of Denali Therapeutics Inc. (DNLI) stock is $17.610. The stock price is -3.98% lower in the session. The intraday range can be seen from this page. Volume of Denali Therapeutics Inc. (DNLI) stock is 2.30M.

Last updated at 16 Oct 2026, 08:00 pm.

Why is the Denali Therapeutics Inc. (DNLI) stock price going up or down today?

The stock price of Denali Therapeutics Inc. (DNLI) can change with earnings, company news, and overall market sentiment. Denali Therapeutics Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Denali Therapeutics Inc. stock expensive at its current price?

Whether Denali Therapeutics Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for DNLI on this page is -6.11. EPS on this page is -2.88. Compare those figures with peers and growth expectations before deciding if the current Denali Therapeutics Inc. price is justified.

How has the stock price of Denali Therapeutics Inc. (DNLI) performed historically?

Historical performance for Denali Therapeutics Inc. (DNLI) is shown on the price chart on this page. Review multi-period moves alongside volume to see how DNLI reacted to past earnings and market events.

Should I buy Denali Therapeutics Inc. (DNLI) stock, at this price?

Buying Denali Therapeutics Inc. (DNLI) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.